CRISPR RNPs advancing Cell & Gene Therapy

RNPs have several attractive properties as a delivery format, particularly in the manufacturing of ex vivo cellular therapies, the most rapidly growing segment for CRISPR therapeutics.

Landing Page Art
Read@2x

READ THE ARTICLE

CRISPR RNPs and the Future of Cell and Gene Therapy by Thomas Lynch, Ph.D., VP Client Services.

Download@2x

CRISPR RIBONUCLEOPROTEINS

From research to clinical. Aldevron offers RNP services to help you turn your CRISPR reagents into therapies.

Chat@2x

TALK TO AN EXPERT

Schedule a 1:1 consultation with Allison Pappas, Ph.D. on how our RNP service can help meet your research and clinical goals.

Pappas, Alison_circle

 

Allison Pappas, Ph.D.

Senior Manager, Client Relations - Gene Editing, Aldevron

Allison Pappas leads Aldevron's Gene Editing Client Relations team and specializes in helping clients obtain high quality gene editing enzymes and RNPs, from Research grade through GMP. She has a strong understanding of GMP requirements, having worked in GMP QC release and stability of biopharmaceuticals before joining Aldevron. Her scientific expertise is in the evolution and characterization of RNA:protein complexes. Dr. Pappas holds a Ph.D. in genetics from Iowa State University and a B.S. in microbiology from Indiana University - Bloomington.

Book A Time